DCGI to discuss regulatory issues with cosmetics companies next week
"The industry has been facing various issues. Earlier it had raised concerns regarding the government's newly notified schedule M that proposed blanket ban on manufacture of any other article or product apart from drugs in the units licensed for drug manufacture. This requirement would mean setting up a new plant exclusively for cosmetic manufacturing," said an industry expert, adding that the requirement was not financially viable.
What's Your Reaction?






